Publications by authors named "T Sagebiel"

Over the past several years, there has been a trend of decreasing screening or diagnostic fluoroscopic examinations ordered by clinical teams, particularly double contrast gastrointestinal studies. The underlying reason is due to increasing number of endoscopic procedures performed by Gastroenterology and Urology and usage of other imaging modalities, which are either more sensitive and/or offer the ability to obtain tissue for confirmation. Many fluoroscopic studies are now tailored toward patients who have undergone gastrointestinal or genitourinary oncologic surgeries, providing both functional and anatomic information, which are important tools for patient management.

View Article and Find Full Text PDF

Introduction: Gastroesophageal adenocarcinoma is relatively common in elderly patients as the incidence increases with age. However, the optimal treatment approach is not well established in this group of patients. The aim of this study is to review our experience for localized gastroesophageal adenocarcinoma in patients aged ≥80 years and to assess association between patient characteristics, clinical factors, and overall survival (OS) in order to optimize the therapeutic approaches for this population.

View Article and Find Full Text PDF

Mucosal melanomas (MMs) are rare and aggressive tumors that arise from melanocytes in the mucosal tissues that line the respiratory, gastrointestinal, and urogenital tracts. Most MMs occur during the 6th and 7th decades of life. MMs may be asymptomatic but may also cause bleeding, pain, and itching, depending on the site of origin.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the usefulness of baseline PET-CT parameters, specifically maximum standardized uptake value (SUVmax) and total lesion glycolysis (TLG), in predicting treatment outcomes for stage 4 gastroesophageal cancer patients.
  • Researchers analyzed data from 129 treatment-naive patients over a median follow-up of 61 months and found no significant influence of PET-CT results on overall survival (OS) or progression-free survival (PFS) regardless of the number of metastatic sites.
  • The findings suggest that detailed PET-CT analyses do not provide valuable prognostic information, indicating limited utility for baseline PET-CT in untreated metastatic gastroesophageal cancer patients.
View Article and Find Full Text PDF